Table 1.
Author (Year) | NCT No. | Country | Population | Endoscopic method | Hypoxemia definition | Hypoxemia risk* | Outcome# |
---|---|---|---|---|---|---|---|
Kim 2021 [22] | NCT03872674 | Korea | 72 | ERCP | SpO2 < 90% | Low | ①② |
Teng 2019 [26] | NCT03138850 | Taiwan | 101 | Esophagogastroduodenoscopy | SpO2 < 90% | Low | ①② |
Mazzeffi 2021[27] | NCT03028688 | America | 262 | Esophagogastroduodenoscopy | SpO2 < 92% | Low | ① |
Lin 2019 [21] | NCT03332433 | China | 1994 | Gastroscopy | SpO2 < 90% | Low | ①② |
Nay 2021 [28] | NCT03829293 | France | 379 | Gastrointestinal endoscopy | SpO2 < 92% | High | ①② |
Riccio 2019 [23] | NCT03148262 | America | 59 | Colonoscopy | SpO2 < 90% | High | ①② |
Thiruvenkatarajan 2021 [24] | CTRN12619000397112 | Australia | 131 | ERCP | SpO2 < 90% | High | ①② |
ERCP endoscopic retrograde cholangiopancreatography
*High: patients were obese (BMI > 30), or had obstructive sleep apnoea syndrome, or were ASA physical status 3 or 4; Low: others
#Outcome include: ①Hypoxemia; ②Need for airway interventions